Username Password
S&P 500: 1,349.74 Change: +0.07%

ALBANY MOLECULAR RESEARCH (AMRI)

Overview
Price 3.06
Price Change Today +$0.06 (+2.00%)
P&P rating Rating: 4
Zacks Rank N/A - N/A
Open Price $3.05
Previous Close $3.00
Daily Range $2.92 - $3.07
52-Week Range $2.08 - $5.55
Volume 88,990
chart
Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.
Other Resources for AMRI
zacks.com
Commentary
Zacks Blog: Zacks #5 Rank Additions for Monday
November 14, 2011
Zacks Blog: Zacks #5 Rank Additions for Thursday
November 10, 2011
Zacks Blog: Zacks #5 Rank Additions for Wednesday
August 10, 2011
Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.
 
Brokerage Analyst Recommendations
1 Brokerage Firms Covering AMRI
 
 
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1
 
AMRI Ratings:BUY  SELL  HOLD
AMRI Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

7 Buy
0 Sell
 
Top Buy Analysis
BUY: AMRI Rating: 4
Company: ALBANY MOLECULAR RESEARCH INC.
Points: -73.34
Start Price: $6.13
Start Date: 07/15/2010 11:38 AM
bullbear
bullbear
P&P Score: 98.29
Recs:
rating upgrade

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
No related Blog Posts.
Commentary
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $6.13
Points: -73.34
Created: 07/15/2010
rating upgrade

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $9.24
Points: -129.14
Created: 04/20/2009
MANY CONTRACTS ON NEW DRUGS IN FINAL STAGES OF TESTING

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $17.46
Points: -86.93
Created: 08/14/2008

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $11.18
Points: -64.67
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $12.51
Points: -67.57
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $9.65
Points: -60.34
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ALBANY MOLECULAR RESEARCH INC. (AMRI) Rating: 4
Start Price: $11.33
Points: -65.03
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
bullbear 98.29 BUY Week or Less 07/15/2010 $6.13 $3.05
(+1.65%)
-50.24% +23.10% -73.34 view
tomfhp 2.10 BUY Six Months to a Year 04/20/2009 $9.24 $3.05
(+1.65%)
-66.99% +62.15% -129.14 view
Vamoose 72.43 BUY One to Three Months 08/14/2008 $17.46 $3.05
(+1.65%)
-82.53% +4.39% -86.93
cips BUY Six Months to a Year 01/01/2008 $11.18 $3.05
(+1.65%)
-72.72% -8.05% -64.67
selllimit 40.94 BUY Six Months to a Year 01/01/2008 $12.51 $3.05
(+1.65%)
-75.62% -8.05% -67.57
Valuetrader 13.34 BUY Six Months to a Year 01/01/2008 $9.65 $3.05
(+1.65%)
-68.39% -8.05% -60.34
eddiec 53.37 BUY Six Months to a Year 01/01/2008 $11.33 $3.05
(+1.65%)
-73.08% -8.05% -65.03
Sponsored Links